A detailed history of Hrt Financial LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 59,779 shares of GILD stock, worth $4.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
59,779
Holding current value
$4.1 Million
% of portfolio
0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$71.58 - $87.29 $4.28 Million - $5.22 Million
59,779 New
59,779 $4.38 Million
Q3 2023

Nov 13, 2023

BUY
$73.94 - $80.67 $338,940 - $369,791
4,584 New
4,584 $343,000
Q1 2023

May 12, 2023

SELL
$77.31 - $88.08 $434,250 - $494,745
-5,617 Reduced 1.89%
290,798 $24.1 Million
Q4 2022

Feb 10, 2023

BUY
$62.32 - $89.47 $18.5 Million - $26.5 Million
296,415 New
296,415 $25.4 Million
Q2 2022

Aug 12, 2022

SELL
$57.72 - $65.01 $3.52 Million - $3.97 Million
-61,019 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$57.92 - $72.58 $3.53 Million - $4.43 Million
61,019 New
61,019 $3.63 Million
Q1 2021

May 17, 2021

SELL
$60.0 - $68.46 $5.23 Million - $5.97 Million
-87,227 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$56.65 - $64.55 $4.94 Million - $5.63 Million
87,227 New
87,227 $5.08 Million
Q3 2020

Nov 13, 2020

SELL
$62.1 - $78.08 $2.59 Million - $3.26 Million
-41,716 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$72.34 - $84.0 $3.02 Million - $3.5 Million
41,716 New
41,716 $3.21 Million
Q4 2019

Feb 14, 2020

SELL
$61.62 - $67.78 $1.1 Million - $1.21 Million
-17,839 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$62.51 - $69.0 $4.7 Million - $5.19 Million
-75,159 Reduced 80.82%
17,839 $1.13 Million
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $5.75 Million - $6.45 Million
92,998 New
92,998 $6.28 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $86B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.